Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Buy
5,530
+9
+0.2% +$614 0.02% 477
2026
Q1
$357K Sell
5,521
-8
-0.1% -$564 0.02% 469
2025
Q4
$386K Hold
5,529
0.02% 451
2025
Q3
$368K Buy
5,529
+104
+2% +$6.91K 0.02% 474
2025
Q2
$325K Buy
5,425
+27
+0.5% +$1.54K 0.02% 492
2025
Q1
$344K Buy
5,398
+8
+0.1% +$465 0.03% 386
2024
Q4
$258K Sell
5,390
-4
-0.1% -$205 0.02% 512
2024
Q3
$309K Buy
5,394
+4
+0.1% +$229 0.02% 491
2024
Q2
$282K Buy
5,390
+4
+0.1% +$175 0.08% 121
2024
Q1
$222K Sell
5,386
-185
-3% -$6.93K 0.02% 513
2023
Q4
$206K Sell
5,571
-179
-3% -$6.74K 0.02% 523
2023
Q3
$220K Hold
5,750
0.02% 458
2023
Q2
$207K Sell
5,750
-150
-3% -$5.12K 0.02% 503
2023
Q1
$225K Hold
5,900
0.02% 428
2022
Q4
$336K Hold
5,900
0.03% 395
2022
Q3
$233K Buy
5,900
+950
+19% +$42K 0.02% 431
2022
Q2
$229K Buy
+4,950
New +$214K 0.02% 462
2022
Q1
Sell
-5,075
Closed -$204K 536
2021
Q4
$204K Buy
+5,075
New +$189K 0.02% 484

Other funds holding HALO

NWAM LLC's HALO Position: Q2 2026 in Review

NWAM LLC increased its Halozyme (HALO) stake by 0.16% in Q2 2026, buying an estimated $614 and bringing the position to 5,530 shares worth $433K. The position accounts for 0.02% of the portfolio, ranked #477.

NWAM LLC first reported a position in HALO in Q4 2021 and has held it in 18 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • NWAM LLC held 5,530 shares of Halozyme worth $433K as of Q2 2026.
  • NWAM LLC bought 9 Halozyme shares in Q2 2026, an estimated $614.
  • Halozyme made up 0.02% of NWAM LLC's portfolio in Q2 2026, its #477 holding.
  • NWAM LLC first reported a position in Halozyme in Q4 2021 and has held it in 18 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.